the First batch of labeled drug from the coronavirus “of Ortigia”, produced and released into circulation. On Friday have informed in a press-service of the operator marking the Centre of development of advanced technologies (CRPT). The quantity is 3354 packaging, reports TASS.
the Medicine is registered in Russia in the second half of may this year, its development belongs to the group of companies “R-Pharm”.
According to the study, the new drug blocks the mediator of inflammation Interleukin-6, which prevents the cytokine storm is one of the most common complications of coronavirus infection COVID-19.